PAPA (Papa Medical) Total Long-Term Assets: $4.58 Mil (As of Mar. 2025)


What is Papa Medical Total Long-Term Assets?

Papa Medical PAPA Total Long-Term Assets is $4.58 Mil as of Mar. 2025.

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Papa Medical's Total Long-Term Assets for the quarter that ended in Mar. 2025 was $4.58 Mil.

Papa Medical Total Long-Term Assets Historical Data

* Premium members only.

The historical data trend for Papa Medical's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Papa Medical Total Long-Term Assets Chart

Papa Medical Annual Data
Trend Dec22 Dec23 Dec24
Total Long-Term Assets
0.78 2.82 4.74

Papa Medical Quarterly Data
Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Assets Get a 7-Day Free Trial Premium Member Only 0.00 3.83 3.67 4.74 4.58

Papa Medical Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Frequently Asked Questions Learn more about Total Long-Term Assets →
What does a Total Long-Term Assets of $4.58 Mil mean?
Papa Medical (PAPA) has a Total Long-Term Assets of $4.58 Mil as of Mar. 2025. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Papa Medical and its competitors.
Is Papa Medical's Total Long-Term Assets too high?
Papa Medical's current Total Long-Term Assets is $4.58 Mil.
How does Papa Medical's Total Long-Term Assets compare to ?
Papa Medical's Total Long-Term Assets of $4.58 Mil can be compared against companies in the Tobacco Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Assets for a Tobacco Products company?
A good Total Long-Term Assets depends on the Tobacco Products industry context. However, Total Long-Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Assets mean?
A high Total Long-Term Assets can signal that a stock is expensive relative to its fundamentals. Total Long-Term Assets are assets that are expected to be realized in cash, sold or consumed longer than one year. View historical data on Papa Medical and its competitors. Papa Medical's current Total Long-Term Assets is $4.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Papa Medical stock overvalued right now?
Papa Medical (PAPA) has a current Total Long-Term Assets of $4.58 Mil. The current Total Long-Term Assets is $4.58 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Assets calculated?
Total Long-Term Assets is calculated from a company's financial statements. For Papa Medical (PAPA), the current Total Long-Term Assets is $4.58 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Papa Medical Business Description

Comparable Companies
Address 202 North California Ave, City of Industry, CA, USA, 91744
Papa Medical Inc is the first end-to-end cannabis dosing solution provider in the U.S. that possesses the medical atomization or nebulizing background and sells nebulizers. The company deeply engages in key activities in the cannabis and consuming E-vapors industry, from research and development, formulation design, e-liquid production, and e-liquid filling to e-liquid co-packing services. It is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis E-vapors.